Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation

NCT03357159 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Graft Versus Host Disease

Interventions

DRUG: Cyclophosphamide
DRUG: anti-human T-lymphocyte immunoglobulin (ATLG)

Sponsor

Sheba Medical Center